Preterm Delivery: Clinical Trials

4 trials for Preterm Delivery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow Preterm Delivery: new trials by email Literature Review of Preterm Delivery trials Research Report on Preterm Delivery

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
dydrogesterone, Micronized progesterone - Preterm Delivery
Phase 3CompletedSanpasitthiprasong Hospital2312015-08-012017-10-10
Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)
17-alpha-hydroxy-progesterone caproate, Makena®, Castor Oil (Placebo) - Preterm Delivery
Phase 2 / Phase 3CompletedObstetrix Medical Group1522011-10-012018-06-28
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
17 alpha-hydroxy progesterone caproate, micronized Progesterone, Control - Preterm Delivery, Neonatal Complications
Phase 3CompletedUniversity of Modena and Reggio Emilia2542010-02-012016-09-23
PREGNANT Short Cervix Trial
progesterone, placebo - Preterm Delivery, Short Cervix
Phase 3CompletedJuniper Pharmaceuticals, Inc.4652008-03-012012-03-13

Narrower conditions

Premature Birth (4)  ·  Obstetric Labor, Premature (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (4)  ·  Obstetric Labor Complications (4)  ·  Pregnancy Complications (4)  ·  Urogenital Diseases (4)  ·  Obstetric Labor, Premature (3)

Interventions

Progesterone (4)  ·  Utrogestan (2)  ·  17 alpha-Hydroxyprogesterone Caproate (1)  ·  17-alpha-Hydroxyprogesterone (1)  ·  Castor Oil (1)  ·  Dydrogesterone (1)

Sponsors

Juniper Pharmaceuticals, Inc. (1)  ·  Obstetrix Medical Group (1)  ·  Sanpasitthiprasong Hospital (1)  ·  University of Modena and Reggio Emilia (1)

Countries

Italy (2)  ·  United States (2)  ·  Belarus (1)  ·  Chile (1)  ·  Czechia (1)  ·  India (1)  ·  Israel (1)  ·  Russia (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Ukraine (1)

Top investigators

Andrew Combs, MD (1)  ·  Fabio Facchinetti, M.D. (1)  ·  George W. Creasy, MD, FACOG (1)  ·  Piyawadee Wuttikonsammakit, MD (1)  ·  Roberto Romero, MD (1)  ·  Sonia Hassan, MD (1)

Results publications

PMID 21472815, PMID 22206581, PMID 22284156, PMID 28594783, PMID 38576410

NIH funding

2009 (1)